There was stereospecific binding of 3H-lofentanil (KD value = 1.53 nM) to membranes of neuroblastoma-glioma NG 108-15 cells which are known to bear high affinity binding sites for enkephalin derivatives (delta-opiate receptor subtype). There was no high affinity specific binding of the mu-opiate specific ligand 3H-sufentanil. The specific binding of 3H-lofentanil to delta-opiate receptor subtype was down-regulated (decrease in Bmax value without change in the KD value) after prolonged incubation of the cells in the presence of leu- and met- enkephalin (0.1 microM). There was no down-regulation of the opiate receptors (3H-lofentanil and 3H-D-ala-D-leu-enkephalin specific binding) after incubation of NG 108-15 cells with drugs from the fentan...
The ontogenetic pattern of multiple opioid binding sites in rat brain from birth until weaning has b...
The selective σ2 receptor antagonist Naltriben (NTB) has played an important role in the identificat...
AbstractWe determined the binding domains of sufentanil and lofentanil in the μ opioid receptor by c...
Down-regulation of H-3 Lofentanil Binding To Opiate Receptors in Different Cultured Neuronal Cell
Specific binding properties of the tritium-labeled delta opiate receptor agonist [3H][2-D-penicillam...
Chronic opioid treatment of Neuro(2A) cells stably expressing either δ- opioid receptor (DOR) or μ-o...
The central hypothesis of this dissertation is that agonists acting at opioid δ or κ (but not μ) rec...
Treatment of rat brain membranes with the irreversible opioid ligand cis -3-methylfentanylisothiocya...
Conditions for the equilibrium binding to opioid receptor of [3H[sufentanil ([mu] selective), [3H][D...
International audienceThe two pharmacological δ-opioid receptor subtypes, δ1 and δ2, have been defin...
The characteristics of t and #{244}opioid receptor sites present in human neuroblastoma SH-SY5Y cell...
The molecular basis for the different pharmacological effects of (mu) (morphine-like) and k (ketazoc...
Certain enkephalin analogues, including those which contain the conformationally restricted amino ac...
According to current concepts, agonists can effect the down-regulation of cell surface receptors, wh...
Abstract: Treatment of rat brain membranes with the irre-versible opioid ligand cis-3-methylfentanyl...
The ontogenetic pattern of multiple opioid binding sites in rat brain from birth until weaning has b...
The selective σ2 receptor antagonist Naltriben (NTB) has played an important role in the identificat...
AbstractWe determined the binding domains of sufentanil and lofentanil in the μ opioid receptor by c...
Down-regulation of H-3 Lofentanil Binding To Opiate Receptors in Different Cultured Neuronal Cell
Specific binding properties of the tritium-labeled delta opiate receptor agonist [3H][2-D-penicillam...
Chronic opioid treatment of Neuro(2A) cells stably expressing either δ- opioid receptor (DOR) or μ-o...
The central hypothesis of this dissertation is that agonists acting at opioid δ or κ (but not μ) rec...
Treatment of rat brain membranes with the irreversible opioid ligand cis -3-methylfentanylisothiocya...
Conditions for the equilibrium binding to opioid receptor of [3H[sufentanil ([mu] selective), [3H][D...
International audienceThe two pharmacological δ-opioid receptor subtypes, δ1 and δ2, have been defin...
The characteristics of t and #{244}opioid receptor sites present in human neuroblastoma SH-SY5Y cell...
The molecular basis for the different pharmacological effects of (mu) (morphine-like) and k (ketazoc...
Certain enkephalin analogues, including those which contain the conformationally restricted amino ac...
According to current concepts, agonists can effect the down-regulation of cell surface receptors, wh...
Abstract: Treatment of rat brain membranes with the irre-versible opioid ligand cis-3-methylfentanyl...
The ontogenetic pattern of multiple opioid binding sites in rat brain from birth until weaning has b...
The selective σ2 receptor antagonist Naltriben (NTB) has played an important role in the identificat...
AbstractWe determined the binding domains of sufentanil and lofentanil in the μ opioid receptor by c...